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Objectives: This cross-sectional study aimed to evaluate the influence of Primary Headache (PH) on efficacy of a Temporomandibular Disorders (TMD) conservative 
therapy and its association with the presence of self-reported parafunctional habits. Sample 
and Methods: Sample was composed of 400 medical records, divided into four groups: I) 
Muscular TMD (n=64); II) Muscular TMD+PH (n=48); III) Muscular TMD+Articular TMD 
(n=173); IV) Muscular TMD+Articular TMD+PH (n=115). All groups had undergone a 
TMD therapy for three months with a stabilization appliance and counseling for habits and 
behavioral changes, with no specific headache management. Current pain intensity and 
existence or not of self-reported bruxism were assessed. Repeated measures ANOVA and 
Chi-Square test followed by Odds were used for statistical analysis, with a significance 
level of 5%. Results: results of this study showed that: (1) A conservative therapy with 
stabilization appliance and counseling for habits and behavioral changes was effective in 
the TMD pain relief; (2) Groups with an additional diagnosis of PH had worsened the pain 
improvement significantly; and (3) no association between the presence of self-reported 
bruxism and PH was found. Conclusions: this study could elucidate the important effect 
that headache may have on the TMD management.
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INTRODUCTION
Primary headache (PH) and chronic orofacial 
pain are common symptoms in the general 
population8, and the presence of headache in 
patients reporting temporomandibular disorders 
(TMD) have a high prevalence of 50 to 80%6,8,28, 
whereas these numbers in patients without TMD 
are only 13 to 23%19,33.
Primary headache individuals could experience 
more severe and frequent symptoms of TMD, and 
vice-versa2,3. The relationship between these two 
entities, however, is not well established in the 
literature yet5,19.
Some studies have shown that TMD therapy 
reduces the complaint of headache in both intensity 
and frequency30, nevertheless, to the best of our 
knowledge, the impact of PH on TMD therapy 
efficacy has not been published yet.
Furthermore, some studies have confirmed 
that the presence of parafunctional habits, i.e., 
activities of the masticatory muscles, as clenching 
and grinding, has an important role in TMD pain, 
whereas patients with sleep bruxism have an 
increased risk for the occurrence of myofascial 
pain15. This association with headache is not well 
defined29.
Based on the above, this study aimed to evaluate 
the influence of the presence of PH on the efficacy 
of a TMD conservative therapy and the association 
with the presence of self-reported parafunctional 
habits. The null hypothesis is that the presence of 
primary headaches does not influence negatively 
the efficacy of TMD management.
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SAMPLE AND METHODS
This study was approved by the Institutional 
Ethics Committee, under protocol #105/2010.
Sample
This cross-sectional study performed 1,200 
evaluations in medical records from an Orofacial 
Pain Clinic, from 1996 to 2009. The sample was 
composed of 400 medical records, initially selected 
according to the following criteria:
Inclusion:
1. Medical records of adults aged 18 years or 
more with:
2. Presence of myofascial pain with or without 
the presence of muscular trigger points by manual 
palpation, according to the American Academy of 
Orofacial Pain (AAOP)11;
Exclusion:
1. Medical records of individuals with neurological 
diseases, fibromyalgia, systemic arthritis, secondary 
headache or paroxysmal hemicrania, menstrual and 
cluster headache.
Group establishment
After fulfilling the initial criteria, the medical 
records were analyzed according to the presence 
or not of TMD through AAOP criteria11; and PH 
based on International Headache Society (IHS)24, 
fulfilling the criteria for migraine and/or tension-
type headache.
Patients could be allocated into one of the four 
groups below:
I) Only muscular TMD (with no headache 
complaint):
This group was composed of 64 medical records 
of subjects with muscular TMD only. Muscular TMD 
encompassed localized myalgia and masticatory 
myofascial pain according to AAOP11.
They had undergone a conservative therapy 
for three months with a rigid acrylic upper full 
coverage stabilization appliance, along with 
counseling for habits and behavioral changes, home 
care instructions, exercises and Physical therapy 
modalities9. Analgesics and anti-inflammatory drugs 
could also be used.
II) Muscular TMD+primary headache:
This group was composed of 48 medical records 
of subjects with muscular TMD plus the presence of 
primary headache. They had undergone the same 
conservative therapy for group I, with no specific 
headache management.
III) Only muscular TMD+articular TMD 
(with no headache complaint):
This group was composed of 173 medical records 
from subjects with muscular and articular TMD. 
They had undergone the same conservative therapy 
for group I.
Articular TMD included arthralgia and disc 
displacement with or without reduction, with or 
without mouth opening limitation, fulfilling the 
AAOP criteria11.
IV) Muscular TMD+articular TMD+primary 
headache:
This group was composed of 115 medical records 
of subjects with muscular and articular TMD plus the 
presence of primary headache. They had undergone 
the same conservative therapy for group I, with no 
specific headache management.
Examiners and variables
Two examiners performed all the medical records 
evaluations. Current pain intensity was analyzed 
according to self-reported pain on Visual Analogue 
Scale (VAS) at baseline and after three months of 
TMD therapy. Moreover, the existence or not of self-
reported clenching/bruxism parafunctional habits 
was analyzed at baseline. The pain experience 
duration, in months, was also recorded.
Data analysis
The results were analyzed with repeated 
measurements ANOVA (after Kolmogorov-Smirnov 
to test normal distribution) to assess within and 
between groups differences; Chi-Square test 
followed by Odds Ratio test, with 95% of Confidence 
Interval (CI), to test association between PH and 
bruxism; and Spearman Correlation to correlate 
pain duration and pain intensity variation between 
baseline and after therapy. The results were 
established with a significance level of 5%.
RESULTS
The mean age was 36.87 years for group I, 
36.79 years for group II, 36.36 for group III, and 
36.79 for group IV (p=0.55). Women were 81.25% 
of group I, 89.58%, 86.12%, and 94.78% of group 
II, III, and IV, respectively.
In the within groups analysis, there was a 
significant reduction in the reported pain for all 
groups (p<0.05) after three months of TMD therapy 
(Figure 1).
Pain improvement in VAS was 70.74% (SD 
30.71) and 46.32% (SD 24.70) for group I and II, 
respectively, and 66.44% (SD 35.37) and 42.56% 
(SD 31.72) for group III and IV, respectively 
(Figure 1). Significant results revealed better pain 
improvement for group I compared to group II, 
and for group III, when compared to group IV 
(p<0.05%) (Figure 1).
At baseline, significant differences for the self-
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Figure 1- Pain intensity according to Visual Analogue Scale (VAS) at baseline and in the end of the therapy
* indicates within-groups differences (p<0.05)
aa indicates no between-groups differences (p>0.05)
ab indicates between-groups differences (p<0.05)
GROUP TOTAL PRESENCE OF CLENCHING/BRUXISM PERCENTAGE
I 64 57 89.06%a
II 48 42 87.50%a
III 173 86 49.71%b
IV 115 59 51.30%b
Table 1- Percentage of clenching/bruxism parafunctional habits between groups
a indicates no between-groups differences (p>0.05)
b indicates between-groups differences (p<0.05)
HEADACHE WITHOUT HEADACHE TOTAL
BRUXISM 101 (41.4%) 143 (58.6%) 244
WITHOUT BRUXISM 62 (39.7%) 94 (60.3%) 156
TOTAL 163 237 400
Table 2- Chi-Square test (X2) and Odds Ratio (OR) of association between primary headache and clenching/bruxism 
parafunctional habits
p=0.743, OR=1.07 (0.71–1.61)
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report of clenching/bruxism were perceived only 
between groups I and II with III and IV, which 
showed that subjects with muscular TMD had at 
baseline a higher percentage of clenching/bruxism 
parafunctional habits than subjects with muscular 
and articular TMD, without considering the presence 
or not of PH (Table 1). No differences were found on 
the association between PH and bruxism (Table 2).
The mean duration of pain experience was 
63.71 months (SD 62.37), 70.95 (SD 76.85), 58.91 
(SD 71.00), and 67.92 (SD 84.38) for group I, II, 
III, and IV, respectively (p=0.10). No significant 
correlation with the pain improvement was detected 
(Spearman R=0.036, p=0.39).
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DISCUSSION
This study evaluated 400 medical records 
regarding the efficacy of TMD management in 
patients with primary headache as a comorbid 
condition. The null hypothesis was rejected. The 
main findings were: (1) a conservative therapy with 
stabilization appliance and counseling for habits and 
behavioral changes was effective in the TMD pain 
relief; (2) the presence of concomitant primary 
headache negatively influenced the efficacy of TMD 
therapy; (3) no association between the presence of 
self-reported bruxism and PH was found; and (4) no 
correlation was found between TMD management 
efficacy on pain severity and the duration of pain 
experience.
Our sample was mainly composed of women 
(88%), aged between 30–45 years (35.47±12.59), 
which is in agreement with epidemiological 
publications17,27. All groups had chronic craniofacial 
pain, with mean duration of 63.72±74.30 months.
After three months of therapy, management 
strategies as stabilization splint and counseling 
for behavioral changes used in the present study 
provided a significant improvement in the pain 
levels of articular and/or muscular TMD when 
judged by the VAS. This management approach is 
supported by the literature and is recommended as 
an effective therapy modality7,16,17,21,22,32.
A possible explanation on the use of this 
management approach is based on a decrease of 
the overload masticatory system2,23. Stabilization 
splints provide proper occlusal relationship, 
reduction in muscular activity, stable physiologic 
mandibular posture; and with the potential 
cognitive and placebo effect20,31. The actual results 
may have an essential correlation with all these 
mechanisms of action. Furthermore, the patient 
education about behavioral changes, the probable 
high impact of the patient’s initial reaction to a 
professional orientation, and also placebo effect, 
natural evolution of the disease and regression 
towards the mean9 may play a role in the pain 
reduction for all groups observed in this study.
After the TMD management, groups with 
additional diagnosis of primary headache did not 
have the same level of amelioration than groups 
with only TMD and without PH. It has been very well 
established that nociceptive impulses arising from 
masticatory muscles and temporomandibular joint, 
as well as cranial tissues and head area, may induce 
central sensitization mechanisms in the subnucleus 
caudalis of the trigeminal nerve system19. Since 
both areas, TMD and head region, share similar 
ascendant pain pathways in the trigeminal system, 
the increase in pain transmission from peripheral 
tissues to the trigeminal system could explain the 
fact that the presence of comorbid PH, not treated, 
could influence negatively a TMD therapy, and the 
approach of both conditions should be stated.
The effectiveness of stabilization devices in the 
management of TMD pain is well documented and it 
is related to the re-establishment of proper occlusal 
relationship; the reduction in muscular activity; the 
cognitive effect, since the patients became aware 
of their oral parafunctional habits; and the placebo 
effect7,9,17,22,32. However, the literature is vague 
about this fact in headache improvement. Some 
studies report headache pain decrease, in both 
intensity and frequency, about 30 to 50% when 
TMD was treated with splint therapy, in short and 
long-term evaluations12,13,30.
The literature suggests that subjects with sleep 
bruxism have increased risk for myofascial and joint 
pain conditions15. In this study, the prevalence of 
clenching/bruxism parafunctional habits was very 
high for all groups.
Some studies had showed that the post-
exercise muscle soreness is associated with this 
overload mechanism of muscle pain in individuals 
with bruxism, which can be a risk factor to the 
installation of myofascial TMD3,10,15. Our results 
show higher prevalence of bruxism in the muscular 
TMD groups only, and lower values in the articular 
TMD groups. It is possible that this outcome could 
be a result of a difference in the pathophysiology 
between the articular and the muscular TMD. In 
the group presenting with articular and muscular 
TMD, the muscle pain might be a consequence of 
the articular pain conditions, which, in turn, could 
lead to a muscle co-contraction. In this case, the 
occurrence of parafunctional habits could not be 
as important as in the case of only muscle pain. 
Furthermore, the prevalence of bruxism in articular 
TMD patients is lower25. Finally, considering that 
muscle pain could be a symptom of bruxism4, in the 
group of only muscular TMD, bruxism could be the 
primary source of pain, which explains the higher 
prevalence in the groups I and II.
The causal relationship between bruxism and 
TMD is controversial. A recent systematic review 
found that studies based on self-report or clinical 
diagnosis of bruxism have a positive association 
with TMD, while studies based on more specific 
quantitative diagnostic methods revealed a weak 
association with symptoms of TMD26. Although 
parafunctional habits increase the activation of 
masticatory muscles18, which sometimes may cause 
pain1, bruxism is not always correlated with the 
pain caused by TMD. In this sense, to establish 
a direct causal relationship between bruxism and 
TMD is difficult.
Our study showed that self-reported bruxism 
was not associated with the presence of PH. A 
recent study evaluated the association between 
TMD, sleep bruxism (SB) and PH. It could be found 
2015;23(2):129-34
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that in patients with painful TMD and SB, only the 
presence of sleep bruxism did not increase the risk 
for any kind of PH14.
No correlation between TMD improvement after 
three months and duration of pain experience 
was found. It was expected that the longer the 
pain experience, the higher the peripheral and 
central sensitization, associated to some sort of 
impairment of the descending inhibitory analgesic 
system, which could influence the efficacy of pain 
management. However, this fact was not tested 
here. The non-administration of central acting 
medication and strategies devoted to revert such 
central alterations could explain this similarity 
between those with more time of pain experience 
and those with less time.
Another limitation of the present study is the 
relatively weak reliability of the data obtained from 
the medical records, usually handled by different 
professionals. Although extracted from records 
from the same treatment center, variations in 
diagnosis and management strategies are expected, 
jeopardizing the present results.
Based on the aforementioned, this study showed 
the potential and significant effect that headache 
has in the efficacy of TMD management. A combined 
approach to both pain conditions is suggested.
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